Document Detail


Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study.
MedLine Citation:
PMID:  21221774     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The diagnosis of cancer can motivate survivors to alter their lifestyle habits. Healthcare providers need to be aware of what changes patients are likely to make in order to derive more pertinent recommendations; however, few studies have reported pre- and post-diagnostic lifestyle behaviours. Semi-quantitative food frequency questionnaires (FFQs) completed approximately 1 year after diagnosis were used to evaluate dietary intake and supplement use before and after diagnosis in a cohort of 1,560 breast cancer patients participating in the UK, prospective DietCompLyf study. Intake of fruit and vegetables, wholegrains and lean sources of protein increased significantly post-diagnosis (P < 0.05, each). Conversely, after diagnosis consumption of high-fat, high-sugar products, red meat, coffee, some alcoholic drinks and refined grains significantly decreased (P < 0.05, each). Post-diagnostic changes in diet were accompanied by changes in the intake of macronutrients and a number of vitamins and minerals. Supplement use was highly prevalent (56.1%) pre-diagnosis, increasing to 62.8% after diagnosis (P = 0.001). Fish oils, multivitamin and minerals, and evening primrose oil were most often used and the proportion of users significantly increased (P < 0.05, each) after diagnosis. The percentage of women using oestrogenic botanical supplements (OBSs) was small but more than doubled to 8.4% after diagnosis (P < 0.05). British women participating in the DietCompLyf study reported significant changes in dietary intake and supplement use after their breast cancer diagnosis. These findings contribute to our understanding of female cancer survivors' dietary behaviours which is crucial for developing and implementing recommendations.
Authors:
Louiza S Velentzis; Mohammed R Keshtgar; Jayne V Woodside; Anthony J Leathem; Ann Titcomb; Katherine Anne Perkins; Monika Mazurowska; Victoria Anderson; Kayleigh Wardell; Marie M Cantwell
Related Documents :
10223754 - Colorectal cancer in inflammatory bowel disease: a continuing problem.
2910754 - Colonoscopic screening of persons with suspected risk factors for colon cancer: ii. pas...
20224864 - Community-based colorectal cancer screening trials with multi-ethnic groups: a systemat...
6934754 - Mass screening in colorectal cancer.
24204934 - Genetic variants in muc4 gene are associated with lung cancer risk in a chinese populat...
18952554 - Extended adjuvant endocrine therapy in breast cancer: current status and future directi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-11
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  -     ISSN:  1573-7217     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cancer Epidemiology Research Unit, Cancer Council NSW, PO Box 572, KINGS CROSS, NSW 1340, Australia, louizav@nswcc.org.au.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammo...
Next Document:  Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain.